Abstract
Introduction
Rheumatoid arthritis (RA) is an inflammatory autoimmune disorder of the joints. It involves loss of bone and cartilage and inflammation of the synovium. Various studies have been performed to investigate the usefulness of PET using [ 18 F]FDG for diagnosis of RA [1] [2] [3] [4] . As RA is an inflammatory disease, tracers that bind to the peripheral benzodiazepine receptor (PBR), also called omega-3 receptor, which is expressed on macrophages, may be of even more interest.
(R)-PK11195 [(R)-1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide] is a ligand that binds to the PBR receptor and can therefore be used as a marker of inflammation. The latter has been demonstrated in both in vitro [5] and in vivo [6] studies. When labelled with 11 C, (R)-[ 11 C]PK11195 concentrations in the body can be quantified using positron emission tomography (PET). In the brain, (R)- [ 11 C]PK11195 binds to activated microglia [7] which are part of the brain's immune system. (R)- [ 11 C] PK11195 has been used extensively to image brain inflammation using PET [8] [9] [10] [11] [12] [13] [14] [15] [16] . Methods have been published regarding the quantification of (R)- [ 11 C] PK11195 binding in the brain [17] [18] [19] . A limited number of studies have been performed in other organs, such as the lung [6, [20] [21] [22] and the heart [23] .
To use PET with the tracer (R)-[ 11 C]PK11195 as a research tool for RA inflammation, a methodology for quantification of (R)- [ 11 C]PK11195 binding in inflamed knee joints in RA using PET has to be available. The purpose of this study was to develop such a methodology.
Materials and methods

Patients
Nine patients (three male, age 54±8 years) were included in the study. Patients were diagnosed with RA according to the criteria of the American College of Rheumatology [24, 25] . For each patient, inflammation was present in at least one knee. The study was approved by the medical ethics committee of the VU University Medical Centre. All patients gave informed consent prior to inclusion.
Scanning protocol
Scans were performed in 3-D acquisition mode using an ECAT EXACT HR+ (CTI/Siemens, Knoxville, TN) PET scanner [26, 27] . All patients underwent a 1-hr dynamic (R)- [ 11 C]PK11195 scan of the knee region with progressively increasing frame durations (one 15 s, one 5 s, one 10 s, two 15 s, two 30 s, three 60 s, four 150 s, five 300 s and two 600 s). A bolus of 490±120 MBq (R)-[
11 C] PK11195 with specific activity higher than 18.5 GBq/μmol at the end of synthesis was injected at the start of the scan. During the scan, arterial radioactivity concentration was monitored continuously using a blood sampler device described previously [28] . In addition, at set times (3, 5, 10, 20, 30, 40 and 60 min after injection), continuous withdrawal was interrupted briefly to collect discrete arterial samples. These samples were used to determine plasma/whole-blood radioactivity concentration ratios and radioactivity concentrations of (R)- [ 11 C]PK11195 and metabolites. Briefly, plasma was processed using solidphase extraction to separate (R)-[ 11 C]PK11195 and its nonpolar metabolites from polar metabolites. (R)- [ 11 C] PK11195 and its nonpolar metabolites were then processed using high-performance liquid chromatography to determine radioactivity concentrations [29] .
Image reconstructions
All emission scans were normalized and corrected for randoms, dead time, scatter [30] , attenuation and decay. All frames of the dynamic emission scans were reconstructed using filtered back projection and a Hanning filter with a cut-off of 0.5 times the Nyquist frequency. In addition, for region of interest (ROI) definition, a summed sinogram from 10 to 60 min after the start of the scan was reconstructed using an ordered subset expectation-maximization (OSEM) algorithm with two iterations and 16 subsets. For both reconstructions, the full-width at half-maximum of the point spread function was approximately 7 mm and the reconstructed voxel size was 1.2×1.2×2.4 mm.
Kinetic analysis
Areas with visually increased uptake in the synovium were delineated using 50% isocontours on the OSEM reconstructed scans. For five patients four to seven areas and for one patient two areas with increased uptake were identified. The ROI volumes were between 1.1 and 2.5 cm 3 . Timeactivity curves (TAC) were created for each ROI. A tracer kinetic model for (R)- [ 11 C]PK11195 has been validated for the brain, where the blood-brain barrier prevents passage of labelled metabolites into the brain. There is, however, no blood-tissue barrier in the knee-cap and it is unknown whether metabolites reach the target region. Therefore, three different input functions were generated: (1) ). These input functions were generated in the following way. The plasma/ whole-blood radioactivity concentration ratio r(t) of the discrete blood samples was fitted to an exponential function. The fraction of (R)- [ 11 C]PK11195 in plasma of the discrete blood samples was fitted to the function
where f(t) is the fraction of radioactivity in plasma originating from (R)- [ 11 C]PK11195 at time t. C p pk was then estimated by multiplying the concentration in whole blood by both r(t) and f(t). C p pk+np was obtained in a similar way, except that the sum of parent compound and nonpolar metabolites was fitted to the function f(t). For C p total only a multiplication of the whole-blood concentration by r(t) was required. Delay between arrival of the (R)- [ 11 C]PK11195 bolus at the external detector and at the place of injection was estimated by fitting a reversible two-tissue compartment model (including a delay parameter) to the sum of all ROIs in the knee using the appropriate input concentration. This (fitted) delay value was then fixed for individual ROIs.
Four compartment models were used to fit the ROI data. These were an irreversible one-tissue model (M1T1K, i.e. one-tissue compartment with one kinetic rate constant), a reversible one-tissue model (M1T2K, one-tissue compartment with two kinetic rate constants), an irreversible twotissue model (M2T3K, two-tissue compartments with three kinetic rate constants), and a reversible two-tissue model (M2T4K, two-tissue compartments with four kinetic rate constants) [31] . Variants of these models with and without a blood volume (V b ) component were evaluated. If the model contained a correction for blood volume, VB was added to the model name, i.e. M1T2KVB instead of M1T2K. For the blood volume term, the (total) radioactivity concentration in blood instead of in plasma was used. Parameters of interest evaluated were the influx rate constant K i for M1T1K and M2T3K, the volume of distribution (V d ) for M1T2K and M2T4K, and additionally binding potential (BP) for M2T4K. For M1T1K, K i is equal to K 1 , while it is equal to K 1 k 3 /(k 2 +k 3 ) for M2T3K. V d is defined as K 1 /k 2 for M1T2K and as K 1 /k 2 (1+BP) for M2T4K, with BP equal to k 3 /k 4 .
For potential use in future clinical applications, where dynamic scanning with arterial blood sampling might be problematic, the performance of the standardized uptake value (SUV) was also evaluated. SUV is the average radioactivity concentration in an ROI, divided by the total injected dose and multiplied by the weight of the subject. It is a semiquantitative measure and is commonly used in oncology for the analysis of FDG scans [32] . SUV was calculated using the average concentrations between 20 and 40 min, 40 and 60 min and 20 and 60 min after injection, respectively.
Due to noise in the data, unrealistic results, such as very high BP or zero K i , were observed. These results were excluded from comparison. For K i M1T1K and K i M1T1KVB, all K i values were in the same range and none had to be rejected. For V d M1T2K, V d M1T2KVB, V d M2T4K and V d M2T4KVB, most values of V d were in the range of 0.5-3 and values were rejected when V d was greater than 3. When K i M2T3K and K i M2T3KVB were used, several K i values were rejected because they became zero, the lower boundary of the fitting algorithm. BP values were rejected when they were greater than 30. To allow a fair comparison between different input types, results were rejected for all input types when they were rejected for any input type.
The optimal model was selected based on a high preference of the Akaike information criterion (AIC) [33] , a low number of unrealistic parameter values and ease of data acquisition. AIC selects the model with the optimal fit to the data, taking into account the number of fitted data points and the number of fitted parameters. When comparing eight models at the same time using AIC, it can be hard to identify the optimal model. Therefore models with and without blood volume were first compared separately. The optimal model was then determined by comparing the optimal models of these comparisons without the lower performing models taken into account. The optimal timing for the calculation of the SUV was determined by a high correlation with the optimal compartment model and preferably short scan duration.
Results
Examples of whole-blood and tissue TAC are shown in Fig. 1 . The ratio of plasma over whole-blood concentration was nearly constant over all samples and patients with a value of 1.55±0.07. It was fitted using a sum of decaying exponents where the number of exponents was based on the AIC. Plasma/whole-blood concentration ratio fits showed little deviation from the measured data. An example is Fig. 2a . The fraction of radioactivity in plasma originating from (R)-[
11 C]PK11195, measured over all patients, changed from 90±3% at 3 min to 54±7% at 60 min after injection. The summed fraction of radioactivity originating from both (R)-[
11 C]PK11195 and nonpolar metabolites was 94±3% at 3 min and 91±3% at 60 min after injection. Three nonpolar metabolites were observed with concentration fractions of 8, 10 and 18% at 60 min after injection. The total polar metabolite fraction was 9±3% at 60 min after injection. Both the fits to the fraction of radioactivity originating from (R)- [ 11 C]PK11195 in plasma and the fits to the fraction of radioactivity originating from (R)- [ 11 C]PK11195 and nonpolar metabolites were fitted using the function f ¼ 1 À a 2 À exp Àbt ð Þ ð À exp Àct ð ÞÞ, where f is parent fraction and a, b, and c are positive fitted parameters. The fits showed little deviation from the measured data (Fig. 2b and c) . All (dynamic) scans were checked for movement artefacts, and for this reason two patients were excluded from further analysis. In one patient, SUV could not be obtained due to a methodological error and only kinetic modelling was performed. Thus, the results from this study are based on the kinetic modelling results from six subjects and the SUV results from five patients.
The number of parameter values that were rejected because they fell outside the physiological range, as defined in the Materials and methods section, varied. The total number of fitted TAC was 33. The highest number of rejected values were observed for K i obtained with M2T3KVB (six for C p pk , five for C p pk+np and five for C p total , respectively) and for BP obtained with M2T4K when C p pk was used as the input function (five). For all other combinations of models and input functions, the numbers of rejected values were two or fewer, i.e. 6% or less of the total number of fits.
The results of various model comparisons using AIC are shown in Tables 1, 2 and 3 . AIC trends were consistent over different input functions. For the models without blood volume correction, M2T4K was preferred in most cases, followed by M1T2K. For the models with blood volume correction, the order of the one-and two-tissue reversible models was reversed. As in both cases a reversible model was optimal, no further results from irreversible compartment models are presented. In general, irreversible models resulted in higher numbers of rejected values than reversible models (data not shown). When M1T2KVB was compared with M2T4K (Table 3) , M1T2KVB was preferred in most cases for all input functions.
A scatter plot of V d M1T2KVB calculated using C p pk and C p total is shown in Fig. 3 . Good correlations were observed between V d M1T2KVB calculated with different 
Discussion
In the present study, three different input functions were used: parent (R)-[ 11 C]PK11195 concentration in plasma (C p pk ), sum of parent (R)-[ 11 C]PK11195 and its nonpolar metabolites concentrations in plasma (C p pk+np ) and total radioactivity concentration in plasma (C p total ). It is likely that all three fractions (i.e. parent, polar and nonpolar metabolite fractions) enter tissue, but with different kinetics. It is not possible to select an optimal model based on theoretical grounds. From a practical point of view, a model should provide good fits to the data and reproducible results. Since the summed fractions of (R)-[
11 C]PK11195 and its nonpolar metabolites decreased from 94±3% at 3 min to 91±3% at 60 min, compared to a constant 100% fraction for C p total , the shape of C p pk+np differed little from that of C p total . This is reflected in the high correlation (R 2 =1.00) between V d M1T2KVB using C p pk+np and C p total . Correlations between C p pk and C p total were lower but still high (R 2 =0.88, Fig. 3 ). Due to the high correlations between C p pk and C p total , clinical performance (i.e. sensitivity to change) would be similar. Compared with C p pk+np and C p pk , C p total has the advantage that no metabolite fractions and plasma concentrations need to be measured. Therefore C p total was taken as the input function of choice. Analysis using AIC indicated that V d M1T2KVB was the preferred parameter (Tables 1, 2, and 3) . Preference for the one-tissue reversible compartment models over the twotissue reversible compartment models is also indicated by the high correlations between these models (R 2 =0.82-0.92, Fig. 4a, b) , suggesting that little additional information was contained within the second compartment. High correlations were also observed between results with and without inclusion of V b (R 2 =0.91-0.96, Fig. 4c, d ). Because AIC indicated that the model including V b was optimal, M1T2KVB was selected as the optimal model. Correlation coefficients between different SUV measures were very high (R 2 =0.99-1.00) and therefore no difference The preference of the models was analysed separately for each input function used. The preference of the models was analysed separately for each input function used. in performance existed between these measures. SUV had lower noise levels than SUV and SUV 40-60 but apparently this did not lead to increased performance, probably because the noise level in a 20-min scan is already low (e.g. very good correlation between SUV 20-40 and SUV ). SUV has the disadvantage of increased risk of patient movement, increased patient discomfort and longer occupation of the scanner. SUV performed similarly to SUV 40-60 but is slightly more patient friendly. The high correlation between V d M1T2KVB and SUV (R 2 =0.73, Fig. 5 ) indicates that SUV 20-40 is a practical alternative when arterial sampling cannot be performed.
Application of the results to clinical trials is limited by the unknown test-retest variance. Knowledge of this variance is relevant in estimating required sample sizes in clinical studies and needs to be assessed in future studies. Three methodological factors may limit the use of (R)-[ 11 C] PK11195 as an inflammation marker in the knee. First, results may be influenced by physiological (normal) uptake of (R)-[ 11 C]PK11195. In most of the patients, however, there was a large difference in the clinical condition of the two knees, and no uptake was observed in the knee with no or limited inflammation. Furthermore, no uptake in healthy controls was observed (data not shown), indicating that high uptake is likely to be related to inflammation. Second, uptake of a metabolite that does not bind to the PBR may also influence quantification. Although this cannot be ruled out, nonpolar metabolites are chemically similar to (R)-[ 11 C]PK11195 and will likely also bind to the receptor. In addition, the majority of the radioactivity concentration originates from the parent compound, which certainly binds to the receptor. The high correlation between the results obtained with the various input functions indicates, however, that the effect of labelled metabolites is small, at least in the present patient population. Third, treatment such as disease-modifying antirheumatic drugs may influence (R)- Fig. 5 Scatter plot between M1T2KVB using C p total as input function and SUV . Different symbols represent different subjects The kinetics of (R)-[ 11 C]PK11195 and its metabolites in the human knee joint affected by RA can best be described by a reversible one-tissue compartment model including a blood volume component. There was a good correlation between distribution volume values independent of whether plasma (R)- [ 11 C]PK11195 concentration, plasma (R)-[ 11 C] PK11195 and nonpolar metabolite concentration or total plasma radioactivity concentration was used as the input function. Based on practical considerations (no metabolite measurements), use of total plasma radioactivity concentration is preferred. Because of the good correlation between V d and SUV calculated using the average radioactivity concentration between 20 and 40 min after injection, the latter is a practical alternative for routine clinical studies.
